These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8609720)

  • 21. Production of interleukin 8 in adult T-cell leukemia cells: possible transactivation of the interleukin 8 gene by human T-cell leukemia virus type I tax.
    Mori N; Murakami S; Oda S; Prager D; Eto S
    Cancer Res; 1995 Aug; 55(16):3592-7. PubMed ID: 7627968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
    Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.
    Portis T; Grossman WJ; Harding JC; Hess JL; Ratner L
    J Virol; 2001 Mar; 75(5):2185-93. PubMed ID: 11160722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures.
    Mastino A; Grelli S; Favalli C; Matteucci C; De Carli M; Garaci E; Macchi B
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2565-74. PubMed ID: 9349477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine mediated growth inhibition of HTLV-I infected transformed human lymphocytes.
    Mochizuki S; Kawamura K; Koshikawa N; Maruyama K
    Leukemia; 1997 Apr; 11 Suppl 3():35-7. PubMed ID: 9209289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.
    Pise-Masison CA; Radonovich M; Sakaguchi K; Appella E; Brady JN
    J Virol; 1998 Aug; 72(8):6348-55. PubMed ID: 9658074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis.
    Nishinaka Y; Nishiyama A; Masutani H; Oka S; Ahsan KM; Nakayama Y; Ishii Y; Nakamura H; Maeda M; Yodoi J
    Cancer Res; 2004 Feb; 64(4):1287-92. PubMed ID: 14983878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1.
    Akagi T; Ono H; Tsuchida N; Shimotohno K
    FEBS Lett; 1997 Apr; 406(3):263-6. PubMed ID: 9136898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells.
    Jung KJ; Dasgupta A; Huang K; Jeong SJ; Pise-Masison C; Gurova KV; Brady JN
    J Virol; 2008 Sep; 82(17):8537-47. PubMed ID: 18550670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response to genotoxic stress in immortalized or transformed human T-lymphotropic virus type I-infected T-cells.
    Cereseto A; Kislyakova T; Washington Parks R; Nicot C; Franchini G
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1575-1581. PubMed ID: 10423124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the Gfi-1 gene in HTLV-1-transformed T cells.
    Sakai I; Yamauchi H; Yasukawa M; Kohno H; Fujita S
    Int J Hematol; 2001 Jun; 73(4):507-16. PubMed ID: 11503967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosome changes associated with growth potential of HTLV-I infected human lymphocytes.
    Kawamura K; Koshikawa N; Mochizuki S; Maruyama K
    Leukemia; 1997 Apr; 11 Suppl 3():32-4. PubMed ID: 9209288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?
    Gillet N; Carpentier A; Barez PY; Willems L
    Retrovirology; 2012 Dec; 9():115. PubMed ID: 23256570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the interferon-gamma and interleukin-10 genes in rabbit HTLV-I-transformed T-cell lines.
    Isono T; Nagano Y; Seto A
    Immunogenetics; 1996; 44(4):306-8. PubMed ID: 8753862
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of HTLV-I-transformed T cell lines.
    Nutman TB
    Curr Protoc Immunol; 2002 May; Chapter 7():Unit 7.20. PubMed ID: 18432891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells.
    Bai XT; Moles R; Chaib-Mezrag H; Nicot C
    J Hematol Oncol; 2015 Oct; 8():117. PubMed ID: 26497583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia.
    Ju W; Zhang M; Petrus M; Maeda M; Pise-Masison CA; Waldmann TA
    Retrovirology; 2014 Jun; 11():43. PubMed ID: 24890041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP.
    Wurm T; Wright DG; Polakowski N; Mesnard JM; Lemasson I
    Nucleic Acids Res; 2012 Jul; 40(13):5910-25. PubMed ID: 22434882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-κB as a target for oncogenic viruses.
    Sun SC; Cesarman E
    Curr Top Microbiol Immunol; 2011; 349():197-244. PubMed ID: 20845110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.
    Van Orden K; Nyborg JK
    Gene Expr; 2000; 9(1-2):29-36. PubMed ID: 11097423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.